Grand Rounds March 1, 2024: Effect of an Intensive Food-As-Medicine Program on Health and Health Care Use: Evidence from a Randomized Clinical Trial (Joseph Doyle, PhD)
Rethinking Clinical Trials
MARCH 6, 2024
There were no significant drops in cholesterol, triglycerides, or fasting glucose and weight did not lower. The treatment group started with a mean 10.3 HbA1c it dropped to a mean of 8.8 at 6 months, which plateaued in 12 months. The control group followed similarly. The study found a null effect on HbA1c.
Let's personalize your content